Abvc Biopharma, Inc.
ABVC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001173313
No open-market purchases or sales by Abvc Biopharma, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.72M in total; no superinvestor holds it.
Other share classesECOC
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +2 vs. previous quarter
- 15
- 13F valueReported value at the end of Q2 2026
- $1.72M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ABVC, Q2 2026
No superinvestor reported holding ABVC at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Abvc Biopharma, Inc. insiders from Form 4, newest first.
No open-market purchases or sales by Abvc Biopharma, Inc. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Abvc Biopharma, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 374,499 | $591.7K | 0.00% | +183,925+96.5% | Added |
| Geode Capital Management, LLC | 228,042 | $360.4K | 0.00% | +6,873+3.1% | Added |
| Vanguard Fiduciary Trust Co | 97,363 | $153.8K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 72,800 | $115.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 72,091 | $113.9K | 0.00% | +72,091 | New |
| BlackRock, Inc. | 56,442 | $89.2K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 48,643 | $76.9K | 0.00% | +16,556+51.6% | Added |
| XTX Topco Ltd | 48,276 | $76.3K | 0.00% | +48,276 | New |
| Panagora Asset Management Inc | 36,682 | $58.0K | 0.00% | +36,682 | New |
| UBS Group AG | 34,123 | $53.9K | 0.00% | +32,352+1,826.8% | Added |